Tagged biosimilars
Press Release
Tanvex BioPharma Forging Strategic Alliance With Bora Pharmaceuticals
Combining Tanvex’s biosimilar development expertise and U.S. FDA-licensed commercial-scale facility in San Diego, California, with Bora’s extensive global CDMO capabilities, the alliance aims to provide comprehensive solutions to biologics CDMO customers around the world. Read More
Press Release
Biologics R&D Data Management: Why Labs Aren't Reaching Their Full Potential & Best Practices to Course Correct, New Webinar Hosted by Xtalks
At the heart of key challenges facing biologics laboratories today lies the volume and complexity of data created throughout the scientific process Read More
Press Release
Global Biosimilars Market to Aggregate $99.28 Billion by 2024 and Grow at a CAGR of 57.03% During the Forecast Period 2018-2024
Factors, such as growing incidence of cancer cases and lifestyle diseases globally, the cost-effectiveness of biosimilars over biologics, and strategic collaboration to develop new biosimilar drugs will increase the market growth during the forecast period. Read More
Press Release
Addressing the Challenges in Biomanufacturing
The life sciences industry is evolving on a global scale. Shifting market demands, health care reforms and more stringent regulations are presenting new challenges to the industry at large. Taking a holistic approach to the challenges and opportunities that biomanufactureres face, Generis' American Biomanufacaturing Summit 2016 will present attendees with first-hand case studies, strategies and best practices to advance manufacturing excellence and drive innovation. Read More
Press Release
Now Source Pharma Comparator, Biosimilars With Confidence From India
Indin an emerging market opens up as source for comparators, biosimilars in the clinical trial market. Sourcing Comparator, biosimilars from traditional markets such as US / EU have been an Achilles heel of the clinical trial industry for quite a while now. Read More
Press Release